PharmaCorp Rx Inc. (TSXV:PCRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.5000
0.00 (0.00%)
At close: Jul 31, 2026

PharmaCorp Rx Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
877963824-
Market Cap Growth
60.62%25.05%648.83%-64.76%--
Enterprise Value
68.5758.2251.636.2221.270
Last Close Price
0.500.460.540.210.60-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
33.3344.00----
PS Ratio
3.623.7910.93---
PB Ratio
1.651.532.093.728.83-
P/TBV Ratio
3.162.623.213.727.19-
P/FCF Ratio
-41.28536.42---
P/OCF Ratio
-39.48506.85---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.852.798.91---
EV/FCF Ratio
-30.34437.24---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.080.0300-
Debt / FCF Ratio
-2.378.07---
Net Debt / Equity Ratio
-0.36-0.41-0.39-0.99-1.01-
Net Debt / EBITDA Ratio
504.0660.229.093.88--
Net Debt / FCF Ratio
20.13-11.12-101.064.3222.74-
Asset Turnover
0.370.410.3100-
Inventory Turnover
5.076.275.50---
Quick Ratio
8.354.677.7948.54166.01-
Current Ratio
9.425.148.5950.24166.01-
Return on Equity (ROE)
-3.19%-3.43%-6.40%-18.85%0.00%-
Return on Assets (ROA)
-2.83%-4.81%-8.77%-22.87%0.00%-
Return on Invested Capital (ROIC)
-5.62%-9.78%-17.64%-7179.63%--
Return on Capital Employed (ROCE)
-1.91%-2.78%-8.96%-23.16%0.00%-

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
FCF Yield
-2.42%0.19%---
Buyback Yield / Dilution
-18.79%-53.12%-102.90%-23.75%--
Total Shareholder Return
-18.79%-53.12%-102.90%-23.75%--